GlassScriptPhysician profile
Michelle L Kearney
NPI 1730427337
$1,701.92
in general payments reported to CMS, 2019-2025
7 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $273 · 2023: $686 · 2024: $417 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,174.35 | 2022-2025 | Penumbra System, Benchmark, Red 72 |
| Abbott Laboratories | $130.00 | 2023 | Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $124.54 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $121.76 | 2023 | Abilify Asimtufii, Abilify Maintena |
| Sanofi-Aventis U.S. LLC | $88.22 | 2024 | |
| Janssen Biotech, INC. | $43.30 | 2024-2025 | Darzalex, Talvey, Tecvayli |
| Takeda Pharmaceuticals U.S.A., INC. | $19.75 | 2024 | Ninlaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Kearney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.